参考文献: [1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 6.2024, November 11, 2024. [2]Turner NC, Im SA, Saura C, et al. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer. N Engl J Med. 2024 Oct 31;391(17):1584-1596. ...
1.NCCN. Clinical Practice Guidelines in Oncology. Breast cancer, version 6.2024. Accessed November 21, 2024. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf 2.Novartis ribociclib (Kisqali®) recognized as Category...
[1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 6.2024, November 11, 2024. [2]Turner NC, Im SA, Saura C, et al. Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer. ...
参考资料: [1]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 1.2024, January 25, 2024. [2]NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. [3]NCCN Clinical Practice Guidelines in Oncolo...
2024 年第 2 版更新要点如下: DCIS-2、BINV-17、BINV-21、BINV-K 2/2 ►新增脚注:FDA 批准的生物仿制药是地舒单抗的合适替代品。 参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. ...
Adjuvant Ribociclib (RIB) Plus Nonsteroidal Aromatase Inhibitor (NSAI) in Patients (Pts) With HR+/HER2− Early Breast Cancer (EBC): 4-Year Outcomes From the NATALEE Trial. LBA13. Proffered Paper presented at the European Society for Medical Oncology Congress; September 16, 2024; Barcelona,...
>>>根据2024 v4 NCCN 指南,SG 被明确列为 mTNBC 二线治疗的全人群 1 类优选推荐,即 SG 可用于在转移性阶段接受过至少一种既往治疗方案的 mTNBC 患者。 >>>2024年更新的 ESMO 转移性乳腺癌在线指南v. 1.1版(ESMO Metastatic Breast Cancer Living Guideline V. 1.1)将 SG 治疗 mTNBC 的 ESMO 临床获益量表...
2024 年第 2 版更新要点如下: DCIS-2、BINV-17、BINV-21、BINV-K 2/2 ►新增脚注:FDA 批准的生物仿制药是地舒单抗的合适替代品。 参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024. ...
2024 年第 2 版更新要点如下: DCIS-2、BINV-17、BINV-21、BINV-K 2/2 ► 新增脚注:FDA 批准的生物仿制药是地舒单抗的合适替代品。 参考文献 [1] NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Breast Cancer, Version 2.2024, March 11, 2024....
2024年1月25日,时隔51天,美国国家综合癌症网络(NCCN)乳腺癌临床实践指南悄然由2023年第5版更新至2024年第1版,全文仍为256页。 NCCN为非国立、全国综合癌症中心联盟组织,1993年11月成立,1995年1月31日正式宣布成为全国联盟,最初由13个美国知名综合癌症中心组成,目前已经增至33个: ...